Displaying 37 - 48 of 87
Metabolism, Alcohol & Toxicity

Summary and conclusion

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Q/A

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introduction to the Event and Keynote Speakers

Webcasts
View
Metabolism, Alcohol & Toxicity

System-based solutions for NAFLD in the UK

Webcasts
View
Metabolism, Alcohol & Toxicity

Current landscape of Non-invasive technologies and the Role of LiverMultiScan Quantitative Multiparametric MRI for Patient Ris...

Webcasts
View
Metabolism, Alcohol & Toxicity

Upcoming NASH Therapeutics; The Need for Non-Invasive Technologies

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introductions

Webcasts
View
Metabolism, Alcohol & Toxicity

Diagnosis of HRS-AKI

Webcasts
View
Displaying 37 - 48 of 87